Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZAX.1400.P03 cream for psoriasis
IRCT20210218050404N5Phase 3Completed
- Sponsor
- Fasa University of Medical Sciences
- Start
- Mar 2022
- Modality
- Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, double-blind trial of ZAX.1400.P03 in psoriasis (2 arms), sponsored by Fasa University of Medical Sciences. Primary endpoint: VAS. Started Mar 2022; status: completed.
02
Drugs
ZAX.1400.P03
03
Conditions
psoriasis
Beyond the preview
Go deeper on IRCT20210218050404N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210218050404N5.